Ribatti D - Search Results

1

MicroRNAs 15a and 16 regulate tumor proliferation in multiple myeloma.

Roccaro AM, Sacco A, Thompson B, Leleu X, Azab AK, Azab F, Runnels J, Jia X, Ngo HT, Melhem MR, Lin CP, Ribatti D, Rollins BJ, Witzig TE, Anderson KC, Ghobrial IM. Roccaro AM, et al. Among authors: ribatti d. Blood. 2009 Jun 25;113(26):6669-80. doi: 10.1182/blood-2009-01-198408. Epub 2009 Apr 28. Blood. 2009. PMID: 19401561 Free PMC article.

2

Bortezomib mediates antiangiogenesis in multiple myeloma via direct and indirect effects on endothelial cells.

Roccaro AM, Hideshima T, Raje N, Kumar S, Ishitsuka K, Yasui H, Shiraishi N, Ribatti D, Nico B, Vacca A, Dammacco F, Richardson PG, Anderson KC. Roccaro AM, et al. Among authors: ribatti d. Cancer Res. 2006 Jan 1;66(1):184-91. doi: 10.1158/0008-5472.CAN-05-1195. Cancer Res. 2006. PMID: 16397231

3

Vascular endothelial growth factor and its receptors in multiple myeloma.

Ria R, Roccaro AM, Merchionne F, Vacca A, Dammacco F, Ribatti D. Ria R, et al. Among authors: ribatti d. Leukemia. 2003 Oct;17(10):1961-6. doi: 10.1038/sj.leu.2403076. Leukemia. 2003. PMID: 14513045 Review.

4

Bortezomib in the treatment of cancer.

Roccaro AM, Vacca A, Ribatti D. Roccaro AM, et al. Among authors: ribatti d. Recent Pat Anticancer Drug Discov. 2006 Nov;1(3):397-403. doi: 10.2174/157489206778776925. Recent Pat Anticancer Drug Discov. 2006. PMID: 18221049 Review.

5

Bone marrow angiogenesis in patients with active multiple myeloma.

Vacca A, Ribatti D, Roccaro AM, Frigeri A, Dammacco F. Vacca A, et al. Among authors: ribatti d. Semin Oncol. 2001 Dec;28(6):543-50. doi: 10.1016/s0093-7754(01)90022-3. Semin Oncol. 2001. PMID: 11740807 Review.

6

Prognostic value of enhanced bone marrow angiogenesis in early B-cell chronic lymphocytic leukemia.

Molica S, Vacca A, Ribatti D, Cuneo A, Cavazzini F, Levato D, Vitelli G, Tucci L, Roccaro AM, Dammacco F. Molica S, et al. Among authors: ribatti d. Blood. 2002 Nov 1;100(9):3344-51. doi: 10.1182/blood-2002-01-0084. Blood. 2002. PMID: 12384436 Free article.

7

Development of vasculature targeting strategies for the treatment of chronic inflammatory diseases.

Ranieri G, Ria R, Roccaro AM, Vacca A, Ribatti D. Ranieri G, et al. Among authors: ribatti d. Curr Drug Targets Inflamm Allergy. 2005 Feb;4(1):13-22. doi: 10.2174/1568010053622966. Curr Drug Targets Inflamm Allergy. 2005. PMID: 15720230 Review.

8

Bone marrow angiogenesis and plasma cell angiogenic and invasive potential in patients with active multiple myeloma.

Vacca A, Ribatti D, Roccaro AM, Ria R, Palermo L, Dammacco F. Vacca A, et al. Among authors: ribatti d. Acta Haematol. 2001;106(4):162-9. doi: 10.1159/000046612. Acta Haematol. 2001. PMID: 11815713 Review.

9

Bortezomib as an antitumor agent.

Roccaro AM, Hideshima T, Richardson PG, Russo D, Ribatti D, Vacca A, Dammacco F, Anderson KC. Roccaro AM, et al. Among authors: ribatti d. Curr Pharm Biotechnol. 2006 Dec;7(6):441-8. doi: 10.2174/138920106779116865. Curr Pharm Biotechnol. 2006. PMID: 17168660 Review.

10

Novel targeting of phospho-cMET overcomes drug resistance and induces antitumor activity in multiple myeloma.

Moschetta M, Basile A, Ferrucci A, Frassanito MA, Rao L, Ria R, Solimando AG, Giuliani N, Boccarelli A, Fumarola F, Coluccia M, Rossini B, Ruggieri S, Nico B, Maiorano E, Ribatti D, Roccaro AM, Vacca A. Moschetta M, et al. Among authors: ribatti d. Clin Cancer Res. 2013 Aug 15;19(16):4371-82. doi: 10.1158/1078-0432.CCR-13-0039. Epub 2013 Jun 26. Clin Cancer Res. 2013. PMID: 23804425

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

924 results

Search Page

Filters